Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS: PVCT · Delayed Price · USD
0.190
-0.010 (-5.05%)
Mar 28, 2024, 1:45 PM EDT - Market open

PVCT Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2001
Net Income
-3.55-6.5-8.43-8.38-8.15-13.52-24.43-24.5-10.24-27.7
Upgrade
Depreciation & Amortization
0.010.010.240.690.690.690.680.680.680.68
Upgrade
Share-Based Compensation
00.020.130.020000.670.530.14
Upgrade
Other Operating Activities
0.55.453.961.482.262.481.815.74-4.8216.99
Upgrade
Operating Cash Flow
-3.04-1.01-4.09-6.19-5.2-10.35-21.94-17.41-13.85-9.89
Upgrade
Capital Expenditures
00000-0.030-0.01-0.07-0.01
Upgrade
Investing Cash Flow
00000-0.030-0.01-0.07-0.01
Upgrade
Dividends Paid
000000-2,045.7900-0.03
Upgrade
Common Stock Issued
00.960.420.270.0803.6413.6511.1218.42
Upgrade
Other Financing Activities
1.373.063.186.495.079.322,0510.554.495.98
Upgrade
Financing Cash Flow
1.374.023.66.755.159.328.9214.215.6124.37
Upgrade
Net Cash Flow
-1.683.01-0.490.54-0.05-1.06-13.01-3.211.714.47
Upgrade
Free Cash Flow
-3.04-1.01-4.09-6.19-5.2-10.38-21.94-17.42-13.92-9.9
Upgrade
Free Cash Flow Margin
-307.52%--------333.10%-
Upgrade
Free Cash Flow Per Share
-0.01-0.00-0.01-0.02-0.01-0.03-0.09-0.09-0.08-0.07
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.